|
|
| AxioMed Spine Corporation (PDF: 865 Kb) |
 | Using a patented polymer under exclusive license from DSM PTG (formerly The Polymer Technology Group), AxioMed Spine Corporation is developing and conducting clinical trials of an artificial disc intended to replicate the natural function of a human disc. (Click here to read more.) |
|
|
|
| Sunshine Heart Inc. (PDF: 1.3 Mb) |
 | Using two polymers provided by Berkeley, Calif. –based DSM PTG ( formerly The Polymer Technology Group), Sunshine Heart is seeking to initiate an IDE (Investigational Device Exemption) feasibility trial of C-Pulse™ — an implantable, non-blood-contacting heart assist therapy for treating patients with moderate to severe heart failure, a condition in which the heart progressively loses its ability to efficiently pump blood throughout the body. (Click here to read more.) |
|
|
|
| CID Vascular (PDF: 25 KB) |
| As a company dedicated to improving the quality of patient care and after-care through the development of innovative, minimally invasive implantable devices, procedures and therapies, Carbostent & Implantable Devices (CID) is continually focused on ways to capitalize on advancements in science and design to improve the performance of its medical devices.. (Click here to read more.) |
|
|
|
| Spinelab |
| As a company that strives to excel in advancing stabilization systems for the spine, Spinelab’s latest development – the Elaspine™ implant system – received the award for Best New Technology for Spine Care in 2010 in the category ‘Motion Preservation’ at the Spine Technology Awards in Orlando, Florida. The system utilizes DSM’s Bionate® PCU, often used in orthopedic applications for its tough, load-bearing qualities. The Elaspine™ implant system was recognized for its originality, clinical relevance and likelihood of improving patient outcomes. As of October 2010, clinical activities across Europe have led to over 20 successfully implanted and documented cases. |
|
|
|
